Loading...
XTAE
ALMD
Market cap7mUSD
Apr 07, Last price  
30.30ILS
1D
-3.81%
1Q
-10.62%
Jan 2017
-73.81%
IPO
-98.83%
Name

Allmed Solutions Ltd

Chart & Performance

D1W1MN
No data to show
P/E
2,047.69
P/S
—
EPS
0.01
Div Yield, %
—
Shrs. gr., 5y
-72.62%
Rev. gr., 5y
16.57%
Revenues
0k
2,563,0002,669,0004,701,0004,916,0005,178,0007,353,0007,703,0009,279,00011,147,0009,719,0005,545,00000
Net income
1m
P
-14,067,000-29,787,000-50,005,000-24,644,000-20,932,000-23,917,000-22,679,000-20,175,00021,988,000-10,893,0001,457,000-11,193,0001,422,000
CFO
7m
P
-13,097,000-29,374,000-13,407,000-19,026,000-15,874,000-17,271,000-18,417,000-16,024,000-12,329,000-8,817,000-5,477,000-10,215,0007,136,000

Profile

Allium Medical Solutions Ltd. develops, manufactures, and sells long-term, fully covered, expandable, and retrievable stents for the treatment of the various obstructions in the urinary and GI tract in Israel and internationally. The company offers ureteric, bulbar, triangular and round prostatic, and biliary stents. Allium Medical Solutions Ltd. is based in Caesarea, Israel.
URL
https://www.allium-medical.com/
IPO date
Feb 01, 2007
Employees
19
Domiciled in
IL
Incorporated in
IL

Valuation

Title
ILS in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
12,072
2,918
Unusual Expense (Income)
NOPBT
(12,072)
(2,918)
NOPBT Margin
Operating Taxes
(947)
Tax Rate
NOPAT
(12,072)
(1,971)
Net income
1,422
-112.70%
(11,193)
-868.22%
Dividends
Dividend yield
Proceeds from repurchase of equity
12,387
BB yield
-56,628.48%
Debt
Debt current
334
195
Long-term debt
1,416
1,141
Deferred revenue
Other long-term liabilities
148
Net debt
(55,351)
(26,395)
Cash flow
Cash from operating activities
7,136
(10,215)
CAPEX
(119)
(438)
Cash from investing activities
(21,597)
2,184
Cash from financing activities
(288)
12,015
FCF
(11,436)
(3,416)
Balance
Cash
57,101
21,032
Long term investments
6,699
Excess cash
57,101
27,731
Stockholders' equity
(203,092)
(204,686)
Invested Capital
259,941
259,463
ROIC
ROCE
EV
Common stock shares outstanding
112
88
Price
0.37
49.40%
0.25
-43.15%
Market cap
42
90.20%
22
-99.94%
EV
(52,758)
(23,932)
EBITDA
(11,596)
(2,368)
EV/EBITDA
4.55
10.11
Interest
46
Interest/NOPBT